· Filed In: Healthcare News
Bennie H. Jeng, MD, Chair of Ophthalmology & Visual Sciences at the University of Maryland School of Medicine, announced today that he has accepted a position at the University of Pennsylvania and will be stepping down as Chair of the Department of Ophthalmology & Visual Sciences at the UM School of Medicine, effective June 30, 2022.
Dr. Jeng, who joined UMSOM in 2013, is a leader in the study of cornea and external diseases, and a distinguished National Institutes of Health (NIH)-funded physician-scientist. His primary interests are in the areas of corneal transplantation, ocular surface disease, ocular microbiology, eye banking, and artificial corneas. He is an alumnus of the University of Pennsylvania, where he received his MD Degree in 1998.
During his tenure at UMSOM, the Department of Ophthalmology made significant advances in clinical care, education, and research. The Department’s clinical footprint has expanded, its education focus is very strong with many students going into Ophthalmology, and the research portfolio has improved.
Dr. Jeng previously served on the faculty of the University of California San Francisco (UCSF) and the Cleveland Clinic.
ABOUT THE UNIVERSITY OF PENNSYLVANIA:
Penn’s history of patient care began more than two centuries ago with the founding of the nation's first hospital, Pennsylvania Hospital, in 1751 and the nation's first medical school at the University of Pennsylvania in 1765. Penn Medicine has pioneered medical frontiers with a staff comprised of innovators who have dedicated their lives to advancing medicine through excellence in education, research and patient care.
DR. BENNIE H JENG, MD:
A leader in the study of cornea and external diseases, Dr. Jeng is a distinguished National Institutes of Health (NIH)-funded physician-scientist. Dr. Jeng's primary interests are in the areas of corneal transplantation, ocular surface disease, ocular microbiology, eye banking, and artificial corneas. He joined the University of Maryland in 2013, having previously served on the faculty of the University of California San Francisco (UCSF) and the Cleveland Clinic, where he established a successful medical and surgical cornea practice.
Dr. Jeng has received funding from the NIH to study ocular surface diseases, and a Research Project Grant (R01) through the FDA to study a novel compound in healing persistent corneal epithelial defects. Dr. Jeng has published more than 90 peer-reviewed manuscripts and 20 book chapters and has delivered more than 200 invited lectures in the US and around the world, including in Kuwait, Australia, and throughout Asia.